Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying.
Size reduction of drug particles to the nanoscale is important in improving the dissolution rate of poorly water-soluble drugs. The aim of this study was to investigate the physicochemical properties of griseofulvin (GF)-lipid nanoparticles and the interactions between GF-lipid nanoparticles and various saccharides during freeze-drying. The phase transition temperature of the GF-lipid nanoparticle suspension was 56.8 degrees C, whereas that of the lipid nanoparticle suspension alone was 57.9 degrees C, indicating that the GF crystals were incorporated into the lipid phase. The mean particle size of a rehydrated suspension of xylose-containing freeze-dried GF-lipid nanoparticles was about 220 nm. However, the mean particle size on the rehydration of nanoparticles containing mannose (monosaccharide), fructose (disaccharide), lactose (disaccharide), or raffinose (trisaccharide) was about 60 nm, suggesting that these saccharides prevented aggregation during the freeze-drying process. Powder X-ray diffraction revealed that xylose existed in the crystalline state in the freeze-dried nanoparticles, whereas the other saccharides existed in amorphous states. Thus, the crystallization of the saccharide was found to be strongly correlated with the aggregation property of the nanoparticles. In the case of freeze-dried xylose, the nanoparticles were squeezed out as the saccharine crystal lattice arranged itself regularly. Then, the ejected nanoparticles were aggregated. In contrast, in the case of the other freeze-dried saccharide, the saccharide remained incorporated with the GF-lipid nanoparticles because its crystal lattice was arranged irregularly. Thus, the particle size was maintained.
Kamiya
Seitaro
S
Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki, Japan. kamiya@niu.ac.jp
Kurita
Takurou
T
Miyagishima
Atsuo
A
Itai
Shigeru
S
Arakawa
Masayuki
M
D055598:Chemical Phenomena; D003460:Crystallization; D004337:Drug Carriers / Q000737:chemistry*; D004339:Drug Compounding; D004355:Drug Stability; D005612:Freeze Drying; D005632:Fructose / Q000737:chemistry; D006118:Griseofulvin / Q000008:administration & dosage*; D007785:Lactose / Q000737:chemistry; D008055:Lipids / Q000737:chemistry*; D008358:Mannose / Q000737:chemistry; D009005:Monosaccharides / Q000737:chemistry*; D053758:Nanoparticles / Q000737:chemistry*; D009844:Oligosaccharides / Q000737:chemistry*; D010316:Particle Size; D033362:Powder Diffraction; D011887:Raffinose / Q000737:chemistry; D013535:Suspensions; D014961:X-Ray Diffraction
D004337:Drug Carriers; D008055:Lipids; D009005:Monosaccharides; D009844:Oligosaccharides; D013535:Suspensions; D005632:Fructose; D006118:Griseofulvin; D007785:Lactose; D011887:Raffinose; D008358:Mannose